Catalyst Oncology Case Studies

1. Tailored Approach Supports Bladder Cancer Breakthrough 3/5/2026

   Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.

2. Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer 11/17/2025

   Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

3. Delivering A Registrational GI Trial Through Ongoing Protocol Shifts 10/17/2025

   A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.

4. Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech 10/2/2025

   This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.

5. Accelerating Approval Pathway For Phase III Ovarian Cancer Trial 8/29/2025

   A late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.